Hypertension is manageable with ACE inhibitors or calcium-channel blockers, whereas proteinuria, thrombo-embolism, and bleeding demand closer scrutiny, especially in combination regimens incorporating anticoagulants [64,72]. The gene discussed is ACE; the disease is Hypertension.